|
16/09/2024
|
14:31
|
PDS: Updated Results, VERSATILE-002 Phase 2 Trial
|
RNS
|
|
13/08/2024
|
15:57
|
PDS Biotech: Business Update and Q2 2024 Results
|
RNS
|
|
02/08/2024
|
12:21
|
Replacement RNS: PDS Biotech Aligns with FDA
|
RNS
|
|
02/08/2024
|
07:00
|
PDS Biotech Aligns with FDA on Phase 3 Trial
|
RNS
|
|
30/07/2024
|
07:00
|
Q-Bot Fundraising
|
RNS
|
|
10/07/2024
|
10:48
|
Result of AGM
|
RNS
|
|
18/06/2024
|
07:00
|
Notice of AGM
|
RNS
|
|
14/06/2024
|
14:10
|
TR-1
|
RNS
|
|
14/06/2024
|
07:00
|
Director/PDMR Shareholding
|
RNS
|
|
13/06/2024
|
07:00
|
Preliminary Results for the year ended 31 Dec 2023
|
RNS
|
|
31/05/2024
|
07:01
|
Notice of Results and Investor Presentation
|
RNS
|
|
31/05/2024
|
07:00
|
DeepTech Recycling: Fundraising, Business Update
|
RNS
|
|
28/05/2024
|
07:00
|
Investment in Wanda, related party transactions
|
RNS
|
|
15/05/2024
|
14:32
|
PDS Biotech: Business Update and Q1 2024 Results
|
RNS
|
|
13/05/2024
|
07:00
|
Martlet Capital: mandate and acquisition
|
RNS
|
|
10/05/2024
|
09:12
|
PDS Biotech: Clinical trial meets study endpoints
|
RNS
|
|
15/04/2024
|
07:00
|
ProAxsis secures c.£1.8mn investment
|
RNS
|
|
27/03/2024
|
13:34
|
PDS Strategy Update and 2023 Financial Results
|
RNS
|
|
13/03/2024
|
07:00
|
Business Update
|
RNS
|
|
05/02/2024
|
07:00
|
Exercise of Options and Issue of Shares
|
RNS
|
|
23/01/2024
|
07:00
|
Glycotest secures $1 million investment
|
RNS
|
|
01/12/2023
|
07:00
|
DeepTech Recycling secures £1 million investment
|
RNS
|
|
14/11/2023
|
16:39
|
PDS BioTechnology: Third Quarter Results
|
RNS
|
|
13/11/2023
|
07:00
|
Director/PDMR Shareholding
|
RNS
|
|
09/11/2023
|
17:28
|
PDS Biotech Announces Updated Survival Data
|
RNS
|
|
06/11/2023
|
07:00
|
Ventive secures c.£900,000 investment
|
RNS
|
|
02/11/2023
|
07:00
|
Change of Adviser
|
RNS
|
|
13/10/2023
|
07:00
|
Exercise of Options
|
RNS
|
|
03/10/2023
|
16:12
|
Director/PDMR Shareholding
|
RNS
|
|
03/10/2023
|
15:21
|
PDS: Interim 24-month survival rate of 74% update
|
RNS
|
|
28/09/2023
|
07:00
|
Interim Results
|
RNS
|
|
14/08/2023
|
17:55
|
PDS Biotech: 2nd Quarter Results, Business Update
|
RNS
|
|
14/08/2023
|
17:51
|
PDS Biotech: Submission of Phase 3 Protocol to FDA
|
RNS
|
|
03/07/2023
|
07:00
|
Grant of Options, Issue of Shares, Director/PDMR
|
RNS
|
|
30/06/2023
|
07:00
|
DName-iT Holdings Limited Fundraising
|
RNS
|
|
29/06/2023
|
11:04
|
Result of AGM & Board Changes
|
RNS
|
|
22/06/2023
|
07:00
|
Vortex Fundraising
|
RNS
|
|
07/06/2023
|
07:00
|
Director/PDMR Shareholding
|
RNS
|
|
06/06/2023
|
07:00
|
Notice of AGM
|
RNS
|
|
31/05/2023
|
07:01
|
Preliminary Results for the year ended 31 Dec 2022
|
RNS
|
|
31/05/2023
|
07:00
|
Board Changes
|
RNS
|
|
15/05/2023
|
15:16
|
PDS Business Update and First Quarter Results
|
RNS
|
|
02/05/2023
|
07:00
|
Glycotest, Inc. Fundraising
|
RNS
|
|
03/04/2023
|
07:00
|
Business Update
|
RNS
|
|
30/03/2023
|
15:51
|
PDS Update
|
RNS
|
|
28/03/2023
|
15:50
|
PDS Business Update and 2022 Financial Results
|
RNS
|
|
28/02/2023
|
07:00
|
Related party loan to ProAxsis Limited
|
RNS
|
|
27/02/2023
|
15:28
|
PDS completes FDA meeting for triple combination
|
RNS
|
|
10/02/2023
|
14:05
|
Second Price Monitoring Extn
|
RNS
|
|
10/02/2023
|
14:00
|
Price Monitoring Extension
|
RNS
|